Health Security Milestone: First FDA-Approved Ebola Vaccine
The U.S. Food and Drug Administration announced today the approval of ERVEBO®, the first FDA-approved vaccine for the prevention of ...
Tag: Vaccines
Ground Breaking Typhoid Vaccine Reduces Infections by 80 Percent in Nepal
A “ground breaking” typhoid vaccine has reduced cases of the bacterial disease by more than 80 percent in a trial ...
Pakistan First Country to Introduce New Typhoid Vaccine to Fight Resistant Strain
Pakistan has become the first country in the world to launch a new vaccine that provides immunity against an extremely ...
Phase 3 Trial of Modified Vaccinia Ankara as a Smallpox Vaccine
In today's New England Journal of Medicine, researchers describe the phase 3 trial results of the newly approved modified vaccinia Ankara ...
Florida’s Hepatitis A Outbreak Nears 3,000 Cases, Prompting Door-to-Door Vaccination Campaign
The Tampa Bay area has been hit especially hard by hepatitis A cases this year. The region has led the ...
Highly Diluted Dose of Ebola Vaccine Shown Effective in Primate Study
A single dose of VSV-Ebola virus vaccine—approximately one-millionth of what is in the vaccine being used in the outbreak outbreak ...
USAMRIID Study Leads to Approval of New Smallpox Vaccine
A new vaccine approved in the U.S. on Sept. 24 prevents both smallpox and the related disease monkeypox in adults. ...
Bavarian Nordic Announces Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
Bavarian Nordic A/S announced on 8 Oct. the initiation of the first-in-human trial of MVA-BN® WEV, a prophylactic vaccine candidate ...
Why Do We Need a New Smallpox Vaccine?
The FDA approved the Jynneos Smallpox and Monkeypox Vaccine last week. The live, non-replicating vaccine is made from a vaccinia ...
FDA Approves Jynneos to Prevent Smallpox and Monkeypox
The U.S. Food and Drug Administration announced today the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the ...
Center for Vaccine Development Awarded up to $201M to Establish Influenza Clinical Core
The Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine (UMSOM) announced that ...
BARDA Exercises First Option in Transition from BioThrax to AV7909 Anthrax Vaccine
The Biomedical Advanced Research and Development Authority (BARDA) has exercised its first contract option with Emergent BioSolutions to procure doses ...
USAID Seeks Innovations in Malaria Vaccine Development
Despite successes in malaria control over the past several decades, over 436,000 people still die from malaria annually and the ...
Counterfeit Medications: What We Know and What Needs to be Done
Nigerian health authorities found a fake version of a meningitis A vaccine, branded Mencevax, on March 15th after the Niger’s health department ...
CRADA Opportunity: Developing Protein Nanoparticles for the Display of Viral Epitopes
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health seeks to partner with one ...
Why Ebola Vaccine on Trial in DRC is Raising Hopes
The World Health Organisation (WHO) has emphasized that an experimental vaccine is playing a major role in controlling the spread ...
US Invests Additional 44 Million in Smallpox Vaccine Manufacturing
Bavarian Nordic A/S announced on Jan. 18 that the U.S. Biomedical Advanced Research and Development Authority (BARDA) has exercised another ...
New Vaccine Manufacturing Innovation Centre Bolsters UK Pandemic Preparedness
The first dedicated Vaccines Manufacturing Innovation Centre (VMIC) is coming to the UK in 2022, addressing gaps in late-stage vaccine ...
CDC Fiscal Year 2019 Broad Agency Announcement
The Centers for Disease Control and Prevention (CDC) works with its partners to monitor health, detect and investigate health problems, ...
Whooping Cough: Tulane Awarded $8.5M to Develop Next-Generation Pertussis Vaccine
Tulane University researchers are developing a vaccine formulation that may provide longer lasting immunity in fewer doses against pertussis, more ...
ADVERTISEMENT.
